n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, K; Jinno, Y; Kaneta, S; Miwa, A; Ogawa, N; Takeuchi, A; Yokoyama, T | 1 |
| Fukushima, H; Harada, K; Jinno, Y; Nishikori, K; Ogawa, N; Ohta, H | 1 |
2 other study(ies) available for n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Coronary Disease
| Article | Year |
|---|---|
Effect of KRN2391 on canine ventricular arrhythmia models.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Digitalis; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Epinephrine; Female; Male; Plants, Medicinal; Plants, Toxic; Pyridines; Vasodilator Agents; Ventricular Function | 1994 |
Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart.
Topics: Animals; Coronary Disease; Cytosol; Glyburide; Heart Rate; In Vitro Techniques; Male; Myocardium; Niacinamide; Nicorandil; Perfusion; Pyridines; Rats; Rats, Inbred Strains; Vasodilator Agents | 1991 |